Dystrophin mutations predict cellular susceptibility to oxidative stress
暂无分享,去创建一个
[1] T. Rando,et al. Integrin-mediated Muscle Cell Spreading , 1999, The Journal of Biological Chemistry.
[2] T. Rando,et al. Regulation of antioxidant enzyme gene expression in response to oxidative stress and during differentiation of mouse skeletal muscle. , 1999, Free radical biology & medicine.
[3] C. Epstein,et al. Copper/zinc superoxide dismutase: More is not necessarily better! , 1999, Annals of neurology.
[4] S. Carbonetto,et al. α-Dystroglycan Is a Laminin Receptor Involved in Extracellular Matrix Assembly on Myotubes and Muscle Cell Viability , 1999, The Journal of cell biology.
[5] N. Hattori,et al. Undetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy , 1999, Neuromuscular Disorders.
[6] S. Froehner,et al. A PDZ-containing Scaffold Related to the Dystrophin Complex at the Basolateral Membrane of Epithelial Cells , 1999, The Journal of cell biology.
[7] G. Macchia,et al. Association of the Dystroglycan Complex Isolated from Bovine Brain Synaptosomes with Proteins Involved in Signal Transduction , 1999, Journal of neurochemistry.
[8] I. Nonaka,et al. α1-Syntrophin Gene Disruption Results in the Absence of Neuronal-type Nitric-oxide Synthase at the Sarcolemma but Does Not Induce Muscle Degeneration* , 1999, The Journal of Biological Chemistry.
[9] K. Campbell,et al. Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction. , 1999, Journal of cell science.
[10] P. Huang,et al. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] I. Hausmanowa-Petrusewicz,et al. A dystrophin missense mutation showing persistence of dystrophin and dystrophin‐associated proteins yet a severe phenotype , 1998, Annals of neurology.
[12] M. Beal,et al. Evidence of oxidative stress in mdx mouse muscle: Studies of the pre-necrotic state , 1998, Journal of the Neurological Sciences.
[13] D. Taverna,et al. Dystrophic Muscle in Mice Chimeric for Expression of α5 Integrin , 1998, The Journal of cell biology.
[14] R. Wollmann,et al. γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin , 1998, The Journal of cell biology.
[15] C. Epstein,et al. Overexpression of copper/zinc superoxide dismutase: A novel cause of murine muscular dystrophy , 1998, Annals of neurology.
[16] D. Wink,et al. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. , 1998, Free radical biology & medicine.
[17] D. Bredt,et al. Muscular Dystrophy in mdx Mice Despite Lack of Neuronal Nitric Oxide Synthase , 1998, Journal of neurochemistry.
[18] K. Campbell,et al. mdx muscle pathology is independent of nNOS perturbation. , 1998, Human molecular genetics.
[19] E. Hoffman,et al. Mutations in the integrin α7 gene cause congenital myopathy , 1998, Nature Genetics.
[20] J. Stull,et al. Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase , 1998, Neuromuscular Disorders.
[21] T. Rando,et al. Muscle cells from mdx mice have an increased susceptibility to oxidative stress , 1998, Neuromuscular Disorders.
[22] M. Shigekawa,et al. Bidirectional Signaling between Sarcoglycans and the Integrin Adhesion System in Cultured L6 Myocytes* , 1998, The Journal of Biological Chemistry.
[23] R. Fässler,et al. Absence of integrin α7 causes a novel form of muscular dystrophy , 1997, Nature Genetics.
[24] J. D. Porter,et al. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy , 1997, Neuromuscular Disorders.
[25] K. Campbell,et al. Muscular dystrophies and the dystrophin-glycoprotein complex. , 1997, Current opinion in neurology.
[26] J. Haycock,et al. Oxidative damage to muscle protein in Duchenne muscular dystrophy , 1996, Neuroreport.
[27] J. Stull,et al. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] D. Bredt,et al. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy , 1996, The Journal of experimental medicine.
[29] M. Jackson,et al. How does dystrophin deficiency lead to muscle degeneration? — Evidence from the MDX mouse , 1995, Neuromuscular Disorders.
[30] K. Widhalm,et al. Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. , 1995, Neuropediatrics.
[31] K. Aldape,et al. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy , 1995, Cell.
[32] J. Faulkner,et al. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. , 1995, Human molecular genetics.
[33] S. Lipton,et al. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[34] John Calvin Reed,et al. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Tidball,et al. Apoptosis precedes necrosis of dystrophin-deficient muscle. , 1995, Journal of cell science.
[36] K. Campbell,et al. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice , 1994, Nature Genetics.
[37] K. Campbell,et al. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy , 1994, Nature Genetics.
[38] K. Campbell,et al. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. , 1994, Human molecular genetics.
[39] H. Blau,et al. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy , 1994, The Journal of cell biology.
[40] M. Passos-Bueno,et al. Half the dystrophin gene is apparently enough for a mild clinical course: confirmation of its potential use for gene therapy. , 1994, Human molecular genetics.
[41] E. Stadtman,et al. Carbonyl assays for determination of oxidatively modified proteins. , 1994, Methods in enzymology.
[42] M. Schwartz,et al. The extracellular matrix as a cell survival factor. , 1993, Molecular biology of the cell.
[43] K. Campbell,et al. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity , 1993, Nature.
[44] J. Mendell,et al. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy , 1993 .
[45] L. Kunkel,et al. The structural and functional diversity of dystrophin , 1993, Nature Genetics.
[46] M. Schwartz. Transmembrane signalling by integrins. , 1992, Trends in cell biology.
[47] K. Davies,et al. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. , 1992, Human molecular genetics.
[48] K. Campbell,et al. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice , 1991, The Journal of cell biology.
[49] P. Walker. Ischemia/reperfusion injury in skeletal muscle , 1991, Annals of vascular surgery.
[50] J. D. Young,et al. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. , 1991, Journal of immunology.
[51] K. Davies,et al. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin , 1990, Nature.
[52] B. Halliwell,et al. Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.
[53] E A Barnard,et al. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.
[54] J P Kehrer,et al. Oxidative stress and muscular dystrophy. , 1989, Chemico-biological interactions.
[55] M. W. Thompson,et al. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. , 1988, Science.
[56] A. Monaco,et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. , 1988, Genomics.
[57] K. Moore,et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.